European Contraceptive Market revenue to reach $8.1 Bn by 2028

Published Date: 2022-06-13

Request a sample

European Contraceptive Market size is estimated to cross USD 8.1 billion by 2028, according to a latest forecast report by Graphical Research.

Growing advancements in contraceptive technology and development will promote the market growth. Around 85%-90% of the contraceptive devices work well owing to advancements in device’s design, material, etc. This significantly augments the preference for such durable and better-quality contraceptives and further augments business revenue. Furthermore, the implementation of advanced technologies in contraceptive development that follow different approaches helps in reducing the spread of sexually transmitted diseases (STDs) and preventing unwanted pregnancies have impacted the industry growth positively. Companies such as Allergan Plc and Cooper Surgical have developed highly effective novel intra-uterine devices that provide a strong combination of advantages for the broad range of birth control product portfolio for women. Additionally, enhancements in design and effectiveness have enabled the convenience of these contraceptives. Wide-ranging R&D activities have introduced advanced contraceptives in the industry that will directly affect the market revenue positively.

The unmet contraceptive needs in developing economies of Europe are leading to the implementation of favorable initiatives, thereby facilitating the market demand. The surging adolescent population across various countries in the region needs easy access to and use of contraceptives to avoid problems such as unsafe abortions, sexually transmitted infections (STIs), unwanted pregnancy, etc. The WHO European regional strategy involves the enhancements and integration of contraceptives services to lessen the prevalence of sexually transmitted infections in the region. The government and non-government organizations are emphasizing on investments to improve and meet the increasing demand for contraceptive tools.

The drugs segment will witness over 5.2% CAGR from 2022 to 2028. Unplanned pregnancies and their consequences mainly among teenage women are leading to developments in contraceptive drugs comprising oral pills for better efficiency and safety of user. Numerous government bodies of European countries have been taking effective measures to promote the usage of contraceptive drugs in order to reduce the number of unwanted pregnancies and the spread of sexually transmitted diseases. For example, as per the UK government, currently, 45% of pregnancies and one-third of births are unplanned that may have adverse health impacts for mothers and children into later in life. Contraceptive drugs also widely known as birth control drugs including oral pills, injectables, and topical contraceptives have proven to be significant in family planning and delivering reliable access to birth-rate management.

Browse detailed statistical insights from the report, “Europe Contraceptives Market Forecast 2028 By Product (Drugs {Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives}, Devices {Condoms [Male, Female], Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermal Implants, Intra-uterine Devices [Copper IUD, Hormonal IUD]}), Research Report, Country Outlook (Germany, UK, France, Spain, Italy), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

Germany contraceptive industry dominated around 14.9% revenue share in 2021, owing to the rapid developments in healthcare infrastructure, rising awareness related to contraceptives and family planning, etc. For instance, in 2019, the German government spent over USD 470 billion on healthcare expenditure. As per the Federal Agency for Statistics, in 2020, around 99,948 unborn babies were aborted in Germany. This statistic indicates the increasing requirement for contraceptives for avoiding unintended pregnancies in the country. Hence, given the extensive implications of unintended pregnancies, the market opportunities for contraceptive drugs & devices are anticipated to experience an upsurge in the coming years. Further, the adoption of novel strategies by the German government to promote access to sexual & reproductive health services and products is expected to improve and amplify the use of contraceptives in the country.

The European contraceptive market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

Europe Market, By Product

  • Drugs
    • Oral Contraceptive Pills
    • Injectable Contraceptives
    • Topical Contraceptives  
  • Devices
    • Condoms
      • Male
      • Female
    • Diaphragms
    • Contraceptive Sponges
    • Vaginal Rings
    • Subdermal Implants
    • Intra-uterine Devices
      • Copper IUD
      • Hormonal IUD

The above information has been provided for the following countries:

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy